Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp > just wow

<< Previous

Bullboard Posts

Next >>

Comment by G1945Von Dec 23, 2020 8:54am

263 Views

Post# 32167904

RE:just wow

Comm'n General, it wasn't all that bad. More getting in on it and now in Sadi Arabia, and that can't be bad.

And when it comes to Zenith, now that we heard more clearly from Don that Zenith (ZHCLF) does, in fact, trade on the OTC Market, and after listening to Don's presentation for the second time, it sure seems that Zenith has a lot going for it.

A lot is going on behind RVX & Zenith's closed doors that we give them credit for.

RVX and Zenith Dec 22 AGM presentations:
RVX: https://118009.choruscall.com/resverlogix/resverlogixagm20201222.pdf

Zenith: https://118009.choruscall.com/zenith/zenithagmdown20201222.pdf

Merry Christmas to all and the best for 2021....G1945V

<< Previous

Bullboard Posts

Next >>

New CEO leads Sonoro Energy's vision to expand in MENA